EPO Patents = 3

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 82(Granted Patents)

Location History:

Tokorogawa, JP (2003)
Tokyo, JP (2003)
Tokorozawa, JP (1993 - 2013)

Company Filing History:

Juridical Foundation the Chemo-sero-therapeutic Research Institute

patents

2 out of 1,278

The University of Tokyo

patents

4. 2 out of 26

Perseus Proteomics Inc.

patents

where one patent can have more than one assignee

Years Active: 1993-2013

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8398981 - Therapeutic agents for alzheimer's disease and cancer (2013-03-19),

2. 8394376 - Therapeutic agents for alzheimer's disease and cancer (2013-03-12),

3. 8226958 - Modified SEB and prophylactics/remedies for immunopathy containing the same (2012-07-24),

4. 7947290 - Protease-resistant modified SEB and vaccine containing the same (2011-05-24),

5. 7314877 - Benzofuran derivative (2008-01-01),

6. 6867221 - Cyclic amine compounds and pharmaceutical composition containing the same (2005-03-15),

7. 6680316 - Pyridazin-3-one derivatives and medicines containing the same (2004-01-20),

8. 6664256 - Phenylpyridazine compounds and medicines containing the same (2003-12-16),

9. 6605620 - Cyclic amine compounds and pharmaceutical composition containing the same (2003-08-12),

10. 6498169 - Cyclic amine compounds and pharmaceutical composition containing the same (2002-12-24),

11. 6403586 - Pyridazine derivatives and drugs containing the same as the active ingredient (2002-06-11),

12. 6395753 - Cyclic amine compounds and pharmaceutical composition containing the same (2002-05-28),

13. 6348468 - Pyridazine compounds and compositions containing the same (2002-02-19),

14. 5354664 - DNA encoding a human thrombomodulin having a modified glycosaminoglycan (1994-10-11),

15. 5273962 - Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) (1993-12-28),

Title: Masao Ohkuchi: Innovator in Therapeutic Agents

Introduction

Masao Ohkuchi is a prominent inventor based in Tokorozawa, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of Alzheimer's disease and cancer. With a total of 15 patents to his name, Ohkuchi's work has the potential to impact many lives.

Latest Patents

Ohkuchi's latest patents focus on developing therapeutic drugs for Alzheimer's disease and cancer. These innovative drugs contain an anti-nicastrin antibody, along with derivatives or fragments of the antibody. His research aims to provide effective treatment options for these debilitating conditions.

Career Highlights

Throughout his career, Masao Ohkuchi has worked with notable organizations, including Kowa Company Limited and the Juridical Foundation the Chemo-sero-therapeutic Research Institute. His experience in these companies has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ohkuchi has collaborated with esteemed colleagues such as Yoshinori Kyotani and Tomoyuki Koshi. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic solutions.

Conclusion

Masao Ohkuchi's dedication to advancing therapeutic agents for Alzheimer's disease and cancer showcases his commitment to innovation in medicine. His contributions are paving the way for future breakthroughs in treatment options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.